| Date | Company | Round | Amount | Co-investors |
|---|---|---|---|---|
| 2010-02-12 | Capnia | Debt | $3.31M | Alliance Venture, Asset Management Ventures, Sagamore BioVentures, Teknoinvest, and Vivo Capital |
| 2009-10-20 | OptiMedica | Series D - II | $5M | Alloy Ventures, CDIB BioScience Venture Management, DAG Ventures, ECICS Management, ITOCHU Techno-Solutions, Kleiner Perkins Caufield & Byers, and Vivo Capital |
| 2009-08-13 | OptiMedica | Series D | $25.04M | Alloy Ventures, CDIB BioScience Venture Management, DAG Ventures, ECICS Management, ITOCHU Techno-Solutions, Kleiner Perkins Caufield & Byers, and Vivo Capital |
| 2007-02-13 | Revance Therapeutics | Unattributed VC | $4M | Essex Woodlands, Technology Partners, and Vivo Capital |
| Avera Pharmaceuticals | Other Investors | Novartis Venture Funds |
